IL2 and type 1 diabetes mellitus: The reduced penetrance of anti-rhIL-2 autoantibodies in T1D patients relative to the NOD mice may be attributed to the genetic and temporal heterogeneity of the human disease, such that only a subset of diabetic patients are phenotypically similar to the NOD model with respect to anti-IL-2 autoantibodies.